- Home
- LILA vs NVAX Comparison
LILA vs NVAX Comparison
Compare LILA & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LILA
- NVAX
- Stock Information
- Founded
- LILA 2017
- NVAX 1987
- Country
- LILA Bermuda
- NVAX United States
- Employees
- LILA N/A
- NVAX N/A
- Industry
- LILA Cable & Other Pay Television Services
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LILA Telecommunications
- NVAX Health Care
- Exchange
- LILA Nasdaq
- NVAX Nasdaq
- Market Cap
- LILA 1.3B
- NVAX 1.3B
- IPO Year
- LILA N/A
- NVAX 1995
- Fundamental
- Price
- LILA $7.52
- NVAX $7.99
- Analyst Decision
- LILA Sell
- NVAX Buy
- Analyst Count
- LILA 1
- NVAX 7
- Target Price
- LILA $6.50
- NVAX $14.29
- AVG Volume (30 Days)
- LILA 490.9K
- NVAX 7.2M
- Earning Date
- LILA 11-05-2025
- NVAX 11-11-2025
- Dividend Yield
- LILA N/A
- NVAX N/A
- EPS Growth
- LILA N/A
- NVAX N/A
- EPS
- LILA N/A
- NVAX 2.54
- Revenue
- LILA $4,409,700,000.00
- NVAX $1,078,718,000.00
- Revenue This Year
- LILA $1.21
- NVAX $61.69
- Revenue Next Year
- LILA $2.90
- NVAX N/A
- P/E Ratio
- LILA N/A
- NVAX $3.25
- Revenue Growth
- LILA N/A
- NVAX 9.22
- 52 Week Low
- LILA $4.26
- NVAX $5.01
- 52 Week High
- LILA $10.79
- NVAX $15.22
- Technical
- Relative Strength Index (RSI)
- LILA 45.80
- NVAX 51.36
- Support Level
- LILA $7.44
- NVAX $7.63
- Resistance Level
- LILA $8.14
- NVAX $8.31
- Average True Range (ATR)
- LILA 0.24
- NVAX 0.35
- MACD
- LILA -0.10
- NVAX -0.00
- Stochastic Oscillator
- LILA 9.51
- NVAX 67.13
About LILA Liberty Latin America Ltd.
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.